Biden cuts off America’s supply of monoclonal antibodies – only “vaccines” allowed

The Biden regime is banning monoclonal antibodies by removing them from emergency use authorization (EUA). The U.S. Food and Drug Administration (FDA) decided out of the blue to cut off America’s supply of Regeneron, a “passive vaccine” that many Democrats seem to oppose because it was promoted by President Donald Trump. (Related: Sen. Rand Paul called out Joe Biden … Continue reading Biden cuts off America’s supply of monoclonal antibodies – only “vaccines” allowed

Texas health systems discriminating against white people, denying them access to monoclonal antibodies

If you are under 65 and have white skin, the MacArthur Medical Center (MMC) in Irving, Tex., will not give you monoclonal antibodies for the Wuhan coronavirus (Covid-19). Because young and middle-aged white people are considered less at risk than pretty much all other demographics when it comes to the Fauci Flu, MMC believes that only non-whites, … Continue reading Texas health systems discriminating against white people, denying them access to monoclonal antibodies

Undergoing COVID treatment has made Allen West’s opposition to vaccine mandates GROW

  Allen West, a former Florida congressman and current Texas Republican gubernatorial candidate, has said that his recent hospitalization for COVID-19 has made him feel even more strongly opposed to vaccine mandates than he had been prior to the ordeal. West had announced over the weekend that he and his wife had both contracted COVID-19. His wife … Continue reading Undergoing COVID treatment has made Allen West’s opposition to vaccine mandates GROW

AstraZeneca begins advanced trials for COVID-19 antibody medication

British pharmaceutical company AstraZeneca has commenced late-stage trials for its COVID-19 antibody drug. In an Oct. 9 statement, the company said that two tests for the AZD7442 long-acting antibody drug, involving 6,000 adult participants worldwide, will look at the medication’s ability to prevent COVID-19 symptoms. A subsequent trial to observe AZD7442’s use as a COVID-19 treatment, involving 4,000 volunteers, … Continue reading AstraZeneca begins advanced trials for COVID-19 antibody medication

Eli Lilly monoclonal antibody drug trial paused over safety concerns

Eli Lilly & Company are halting the enrollment of participants in a clinical trial of its antibody treatment for the Wuhan coronavirus (COVID-19) due to safety concerns. According to company spokeswoman Molly McCully, an independent data and safety monitoring board (DSMB) had recommended pausing enrollment in the U.S. government-sponsored trials. Lilly, however, did not say what caused the panel … Continue reading Eli Lilly monoclonal antibody drug trial paused over safety concerns